Rang	Name	Position
1	Mr. Robert M. Davis J.D.	Chairman, President & CEO
2	Ms. Caroline A. Litchfield	Executive VP & CFO
3	Ms. Jennifer L. Zachary J.D.	Executive VP & General Counsel
4	Dr. Dean Y. Li M.D., Ph.D.	Executive VP & President of Merck Research Laboratories
5	Mr. Dalton E. Smart III	Senior VP of Finance, Principal Accounting Officer & Global Controller
6	Mr. David Michael Williams	Executive VP and Chief Information & Digital Officer
7	Mr. Peter Dannenbaum	Vice President of Investor Relations
8	Mr. Chirfi Guindo	Executive Vice President of Strategic Access, Policy & Communications
9	Ms. Betty D. Larson	Executive VP & Chief Human Resources Officer
10	Mr. Richard R. DeLuca Jr.	Executive VP & President of Merck Animal Health

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	10,30%	31,64 Mrd. USD
2	BlackRock Inc	9,14%	28,09 Mrd. USD
3	Vanguard Capital Management, LLC	6,52%	20,03 Mrd. USD
4	State Street Corp	4,83%	14,84 Mrd. USD
5	Wellington Management Company LLP	3,41%	10,49 Mrd. USD
6	Vanguard Portfolio Management, LLC	2,73%	8,37 Mrd. USD
7	Geode Capital Management, LLC	2,41%	7,41 Mrd. USD
8	JPMorgan Chase & Co	2,14%	6,59 Mrd. USD
9	Charles Schwab Investment Management Inc	2,01%	6,19 Mrd. USD
10	Morgan Stanley - Brokerage Accounts	1,93%	5,93 Mrd. USD
11	FMR Inc	1,80%	5,54 Mrd. USD
12	NORGES BANK	1,54%	4,73 Mrd. USD
13	Bank of America Corp	1,25%	3,83 Mrd. USD
14	Northern Trust Corp	1,10%	3,37 Mrd. USD
15	Fisher Asset Management, LLC	1,07%	3,29 Mrd. USD
16	T. Rowe Price Associates, Inc.	0,93%	2,87 Mrd. USD
17	Amvescap Plc.	0,88%	2,72 Mrd. USD
18	UBS Asset Mgmt Americas Inc	0,83%	2,54 Mrd. USD
19	The Goldman Sachs Group Inc	0,82%	2,51 Mrd. USD
20	Legal & General Group PLC	0,79%	2,43 Mrd. USD